IEQ Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2M | Sell |
6,122
-37,892
| -86% | -$12.4M | 0.01% | 643 |
|
|
2025
Q1 | $11.9M | Buy |
44,014
+5,208
| +13% | +$1.41M | 0.09% | 168 |
|
|
2024
Q4 | $9.13M | Buy |
38,806
+34,613
| +825% | +$8.14M | 0.09% | 144 |
|
|
2024
Q3 | $1.15M | Buy |
4,193
+1,153
| +38% | +$317K | 0.01% | 498 |
|
|
2024
Q2 | $739K | Buy |
3,040
+1,550
| +104% | +$377K | 0.01% | 545 |
|
|
2024
Q1 | $223K | Buy |
+1,490
| New | +$223K | ﹤0.01% | 855 |
|
|
2023
Q4 | – | Sell |
-1,540
| Closed | -$273K | – | 931 |
|
|
2023
Q3 | $273K | Buy |
1,540
+41
| +3% | +$7.26K | 0.01% | 751 |
|
|
2023
Q2 | $285K | Buy |
1,499
+194
| +15% | +$36.8K | 0.01% | 695 |
|
|
2023
Q1 | $261K | Sell |
1,305
-142
| -10% | -$28.4K | 0.01% | 757 |
|
|
2022
Q4 | $344K | Buy |
1,447
+55
| +4% | +$13.1K | 0.01% | 596 |
|
|
2022
Q3 | $279K | Buy |
+1,392
| New | +$279K | 0.01% | 682 |
|